LBD
BIIB icon

Landsberg Bennett & Dubbaneh’s Biogen BIIB Stock Holding History

Landsberg Bennett & Dubbaneh’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-1,025
Closed -$237K – 219
2019
Q1 		$237K Buy
1,025
+191
+23% +$60.1K 0.06% 197
2018
Q4 		$251K Buy
+834
New +$266K 0.1% 173

Other funds holding BIIB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Landsberg Bennett & Dubbaneh's BIIB Position: Q2 2019 in Review

Landsberg Bennett & Dubbaneh sold out of Biogen (BIIB) in Q2 2019, closing a stake of 1,025 shares — an estimated $237K sold.

Landsberg Bennett & Dubbaneh first reported a position in BIIB in Q4 2018 and held it in 2 quarters. The position peaked at $251K in Q4 2018. 1,010 funds tracked by Wall St. Rank hold BIIB as of Q2 2019.

  • Landsberg Bennett & Dubbaneh reported no remaining Biogen position as of Q2 2019 after selling out during the quarter.
  • Landsberg Bennett & Dubbaneh sold 1,025 Biogen shares in Q2 2019, an estimated $237K.
  • Landsberg Bennett & Dubbaneh first reported a position in Biogen in Q4 2018 and held it in 2 quarters.
  • Landsberg Bennett & Dubbaneh's Biogen position peaked at $251K in Q4 2018.
  • 1,010 funds tracked by Wall St. Rank held Biogen as of Q2 2019.

Based on Landsberg Bennett & Dubbaneh's 13F filing for Q2 2019, filed 23 Jul 2019.